BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2459000)

  • 1. The comeback of hirudin--an old-established anticoagulant agent.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):10-23. PubMed ID: 2459000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches.
    Markwardt F
    Biomed Biochim Acta; 1985; 44(7-8):1007-13. PubMed ID: 3910034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and evaluation of recombinant hirudin.
    Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
    Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comeback of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
    [No Abstract]   [Full Text] [Related]  

  • 6. Hirudin: a family of iso-proteins. Isolation and sequence determination of new hirudins.
    Tripier D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):30-5. PubMed ID: 2459028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.
    Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ
    Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
    Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
    Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hirudin and hirudin fragments].
    Deschamps A; Samama M
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative properties of hirudin from whole leeches and from leech heads and bodies].
    Baskova IP; Cherkesova DU
    Biokhimiia; 1980 Feb; 45(2):267-72. PubMed ID: 7388067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of selective thrombin inhibitors.
    Markwardt F
    Nouv Rev Fr Hematol (1978); 1988; 30(3):161-5. PubMed ID: 3047669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past, present and future of hirudin.
    Markwardt F
    Haemostasis; 1991; 21 Suppl 1():11-26. PubMed ID: 1894186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular drug highlight: hirudin.
    Cheng-Lai A
    Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin.
    Kaiser B; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):41-6. PubMed ID: 2459030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
    Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of the anticoagulant hirudin: its biotechnological production and clinical practice.
    Sohn JH; Kang HA; Rao KJ; Kim CH; Choi ES; Chung BH; Rhee SK
    Appl Microbiol Biotechnol; 2001 Dec; 57(5-6):606-13. PubMed ID: 11778867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.